Dopamine induced neurodegeneration in a PINK1 model of Parkinson's disease.
about
The spatiotemporal regulation of the Keap1-Nrf2 pathway and its importance in cellular bioenergeticsMitochondrial dysfunction and oxidative stress in Parkinson's diseaseATP13A2 deficiency induces a decrease in cathepsin D activity, fingerprint-like inclusion body formation, and selective degeneration of dopaminergic neuronsFuzzy Decision Making Approach to Identify Optimum Enzyme Targets and Drug Dosage for Remedying Presynaptic Dopamine DeficiencyCytosolic sulfotransferase 1A3 is induced by dopamine and protects neuronal cells from dopamine toxicity: role of D1 receptor-N-methyl-D-aspartate receptor couplingPathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates.Central dopaminergic system and its implications in stress-mediated neurological disorders and gastric ulcers: short review.Downregulation of Pink1 influences mitochondrial fusion-fission machinery and sensitizes to neurotoxins in dopaminergic cells.2, 2'- and 4, 4'-Cyanines are transporter-independent in vitro dopaminergic toxins with the specificity and mechanism of toxicity similar to MPP⁺.Stress-mediated modulations in dopaminergic system and their subsequent impact on behavioral and oxidative alterations: an update.Calcium signaling in Parkinson's disease.Impaired mitochondrial homeostasis and neurodegeneration: towards new therapeutic targets?The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans.A Comprehensive View of the Neurotoxicity Mechanisms of Cocaine and Ethanol.PKA Phosphorylation of NCLX Reverses Mitochondrial Calcium Overload and Depolarization, Promoting Survival of PINK1-Deficient Dopaminergic NeuronsDopamine protects neurons against glutamate-induced excitotoxicity.Characterization of early-onset motor deficits in the Pink1-/- mouse model of Parkinson disease.Carbon monoxide shifts energetic metabolism from glycolysis to oxidative phosphorylation in endothelial cells.Portraying the Effect of Calcium-Binding Proteins on Cytosolic Calcium Concentration Distribution Fractionally in Nerve Cells.Altered expression of DJ-1 and PINK1 in sporadic ALS and in the SOD1(G93A) ALS mouse model.Neuroprotective strategies to prevent and treat Parkinson's disease based on its pathophysiological mechanism.Gene-by-environment interactions that disrupt mitochondrial homeostasis cause neurodegeneration in C. elegans Parkinson's models.Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease.α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease.
P2860
Q26778368-511A0886-3167-45A0-83F5-53124EA1DBF3Q27014051-E8231416-1D86-4672-96E8-FCBA101834FDQ28119120-BC974664-D45E-422B-976D-B3CD4CED7D73Q28554723-78612700-E7A9-4E1A-9A59-31CBAC889FF5Q28910380-ED1F2F5A-A427-4DF5-B5B5-0B931F46FABEQ33687447-8B73CC1A-2CB6-4331-BA87-5B43725D3B11Q36253550-A58F8549-877C-4298-B730-E1C49FF4C16BQ36651556-A2D4B1A5-1E4C-42EE-B688-5A45810E3078Q36692394-51FC4B84-FA54-41F8-955D-7582A5DEBE3BQ38154648-AD23172C-649C-479E-A519-E16C6B35389FQ38208179-90679C32-3DA2-4D7F-94CB-C5F189F66D78Q38248695-1CBCBA08-4A60-47DB-8729-6BE95FF662AFQ38279572-5435330C-12BC-42AB-B3E8-2F37C3610F3EQ38536415-D90AFAF8-B2BE-4177-BA99-0E606E611D13Q38829987-8F9BEAB2-2CEB-4397-988B-73EF3886E4A8Q43159528-BE46449E-FB24-408E-AFF7-6258F9C713CFQ47327885-1C12B66C-3802-41E0-AC21-86CCF4D91E7FQ48053769-1D66787D-DD81-4BEC-9ABD-AF4E61D0F3D4Q48418523-6C30EDAB-3800-400B-95B4-949EA5D218FAQ48932124-532A32E4-A6D8-4CC4-997C-1E8BAA0D1735Q49797218-155D2B30-0BA5-486F-8CA7-A8F0D07AC94AQ54987165-1265CFB9-F5FC-4737-AEC9-9F7306E4286DQ55048859-50D28DC7-148B-43B1-B8CF-6AE088DAE9FDQ55221371-F8657D2B-03DB-45E9-9BD3-9DD421A00C1F
P2860
Dopamine induced neurodegeneration in a PINK1 model of Parkinson's disease.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Dopamine induced neurodegeneration in a PINK1 model of Parkinson's disease.
@ast
Dopamine induced neurodegeneration in a PINK1 model of Parkinson's disease.
@en
Dopamine induced neurodegeneration in a PINK1 model of Parkinson's disease.
@nl
type
label
Dopamine induced neurodegeneration in a PINK1 model of Parkinson's disease.
@ast
Dopamine induced neurodegeneration in a PINK1 model of Parkinson's disease.
@en
Dopamine induced neurodegeneration in a PINK1 model of Parkinson's disease.
@nl
prefLabel
Dopamine induced neurodegeneration in a PINK1 model of Parkinson's disease.
@ast
Dopamine induced neurodegeneration in a PINK1 model of Parkinson's disease.
@en
Dopamine induced neurodegeneration in a PINK1 model of Parkinson's disease.
@nl
P2093
P2860
P50
P1433
P1476
Dopamine induced neurodegeneration in a PINK1 model of Parkinson's disease.
@en
P2093
Annika Vaarmann
Sonia Gandhi
P2860
P304
P356
10.1371/JOURNAL.PONE.0037564
P407
P577
2012-05-25T00:00:00Z